Aleutian Disease (parvovirus)

Aleutian disease, caused by Aleutian mink disease parvovirus, is a serious viral infection that affects ferrets and mink. Originally identified in ranch mink, particularly the Aleutian color variant which showed extreme susceptibility, this disease was subsequently recognized in domestic ferrets where it causes a chronic, progressive immune-mediated condition. The virus triggers an abnormal immune response that leads to plasmacytosis, the accumulation of antibody-producing plasma cells throughout the body, and hypergammaglobulinemia, an excessive elevation of circulating antibodies. Rather than protecting the ferret, this exaggerated immune response causes immune complex deposition in vital organs, leading to progressive damage.

Aleutian disease affects domestic ferrets worldwide, though prevalence varies significantly by region and population. The disease is found wherever ferrets are kept, with higher rates typically seen in breeding colonies, shelters, and multi-ferret households where virus transmission opportunities are increased. Seroprevalence studies have shown varying rates from a few percent to over fifty percent in different populations. Many infected ferrets remain asymptomatic carriers for extended periods, making disease control challenging. The actual impact of infection depends on viral strain virulence, individual ferret genetic factors, and immune status at the time of infection.

The impact of Aleutian disease on affected ferrets varies enormously from asymptomatic lifelong carrier status to rapid fatal disease. Some ferrets harbor the virus for years without apparent illness, while others develop progressive wasting, organ failure, and death. When clinical disease develops, it typically affects multiple organ systems including the kidneys, liver, and nervous system. The chronic inflammatory state causes progressive deterioration in health and quality of life. The unpredictable nature of disease expression, where apparently healthy carriers can suddenly develop clinical disease or spread infection to other ferrets, creates significant challenges for ferret owners and breeders.

There is currently no cure for Aleutian disease, and no vaccine is available for ferrets. Management focuses on supportive care to maintain quality of life and prevent transmission to uninfected ferrets. Diagnosis through testing allows informed decisions about housing, quarantine, and management of positive ferrets. While a positive test result can be distressing for owners, many ferrets live comfortable lives for extended periods after diagnosis. Working with a veterinarian experienced in ferret medicine helps optimize care and monitoring for affected individuals while protecting negative ferrets in the same household or facility.

The primary cause of Aleutian disease is infection with Aleutian mink disease parvovirus, a member of the Parvoviridae family. This small, non-enveloped DNA virus is highly resistant in the environment, able to survive for months to years under favorable conditions. The virus specifically infects mustelids including ferrets and mink, with different strains showing varying host preferences and virulence. Ferret-adapted strains have evolved that spread readily among ferret populations. The virus targets cells of the immune system and persists in the body indefinitely, establishing chronic infection that the immune system cannot clear despite producing abundant antibodies.

Transmission of Aleutian disease virus occurs through multiple routes, making control challenging in multi-ferret environments. Direct contact between infected and susceptible ferrets allows transmission through saliva, urine, feces, and other bodily fluids. The virus can survive in the environment for extended periods, allowing indirect transmission through contaminated cages, bedding, food dishes, and other fomites. Vertical transmission from infected mothers to offspring during pregnancy or nursing occurs, potentially establishing infection in kits before they leave breeding facilities. The virus is not transmitted to humans or other non-mustelid pets, but ferret owners can carry virus on hands or clothing between animals.

Risk factors for Aleutian disease infection include exposure to infected ferrets or contaminated environments. Ferrets from breeding facilities, pet stores, shelters, or rescue organizations where multiple ferrets congregate face higher exposure risk. Multi-ferret households have increased transmission opportunity, particularly when introducing new ferrets without quarantine or testing. Attending ferret shows or events where ferrets from multiple sources mingle creates exposure risk. Young ferrets and those with compromised immune systems may be more susceptible to infection and more likely to develop clinical disease following exposure. Geographic areas with higher ferret population density generally have higher viral prevalence.

Environmental factors that contribute to virus persistence and transmission include inadequate disinfection practices. The parvovirus is resistant to many common disinfectants and requires specific agents including bleach, potassium peroxymonosulfate, or accelerated hydrogen peroxide for effective inactivation. Failure to properly clean and disinfect between animal groups allows environmental transmission. Crowded housing increases both direct and indirect transmission opportunities. Stress from overcrowding, poor nutrition, or other illness can facilitate infection establishment and disease progression. Climate conditions affect viral environmental survival, with the virus persisting longer in cool, damp conditions.

The pathophysiology of Aleutian disease involves an aberrant immune response to persistent viral infection. The virus establishes chronic infection that the immune system cannot eliminate despite mounting a robust antibody response. The excessive antibody production leads to hypergammaglobulinemia with dramatically elevated gamma globulin levels. These antibodies form immune complexes with viral antigens that circulate and deposit in tissues including the kidneys, liver, blood vessels, and other organs. The deposited immune complexes trigger local inflammation and progressive tissue damage. This immune complex disease causes the organ dysfunction and clinical signs seen in symptomatic ferrets. The severity of disease correlates with the degree of immune response rather than viral load, explaining why some carriers remain asymptomatic while others develop severe disease.

Early warning signs of Aleutian disease can be extremely subtle or entirely absent in many infected ferrets. Many ferrets remain asymptomatic carriers for months to years following infection, making detection based on clinical signs alone unreliable. When early signs do appear, they are often vague and non-specific, including mild weight loss, reduced appetite, and decreased energy that owners may attribute to other causes or aging. Subtle changes in coat quality or mild muscle wasting may be noticed by attentive owners. The gradual onset of symptoms means that significant disease progression may occur before clinical signs become obvious enough to prompt veterinary evaluation.

Common visible symptoms of clinical Aleutian disease develop as immune-mediated organ damage progresses. Progressive weight loss despite maintained appetite is characteristic, giving the condition one of its common names, wasting disease. Muscle wasting leads to visible loss of body condition, particularly noticeable over the spine and hindquarters. Enlarged lymph nodes may be palpable under the jaw, in the armpits, or in the groin. The spleen may become enlarged, sometimes causing visible abdominal distension. Coat quality often deteriorates with rough, dull fur. Pale gums may indicate anemia resulting from chronic disease. Increased thirst and urination suggest kidney involvement.

Behavioral changes in ferrets with Aleutian disease reflect declining health status. Reduced activity and playfulness progress as the disease advances. Affected ferrets may spend more time sleeping and less time engaging in normal ferret activities like exploring and playing. Appetite changes may occur, with some ferrets eating less while others maintain good appetite despite weight loss. Social interactions may decrease as energy levels decline. Some ferrets develop irritability or changes in temperament. Ferrets that previously enjoyed interaction may become withdrawn or less responsive. These behavioral changes often parallel physical deterioration.

Physical signs reflecting organ involvement become apparent as disease progresses. Neurological signs including hind leg weakness, incoordination, tremors, or paralysis develop in some cases when immune complexes affect the nervous system. This presentation is sometimes called posterior paresis and can progress to complete inability to use the hind legs. Breathing difficulties may indicate lung involvement or secondary respiratory infection. Bleeding tendencies including nose bleeds, bloody stool, or prolonged bleeding from minor wounds can occur. Tarry black stool suggests gastrointestinal bleeding. Jaundice causing yellow discoloration of gums, ear tips, and skin indicates liver involvement. Eye problems including inflammation may develop.

Symptom progression in Aleutian disease is typically slow and chronic, occurring over months to years rather than days to weeks. However, the course is highly variable between individuals. Some ferrets remain stable for extended periods before experiencing decline. Others show steady deterioration from the time symptoms first appear. Acute crisis episodes can occur when organ damage reaches critical levels or secondary infections develop. The nervous system form may progress more rapidly once neurological signs appear. Without effective treatment options, the trajectory is generally progressive decline once clinical disease is established, though the timeline remains unpredictable.

Emergency symptoms requiring immediate veterinary attention include sudden severe weakness or collapse, which may indicate severe anemia, internal bleeding, or critical organ failure. Inability to walk or stand, particularly if progressing rapidly, requires urgent evaluation. Severe respiratory distress suggests serious lung involvement or secondary pneumonia. Signs of severe dehydration including sunken eyes, skin tenting, and extreme lethargy need immediate attention. Seizures or sudden severe neurological deterioration constitute emergencies. Any ferret with known Aleutian disease showing acute worsening of symptoms should be evaluated promptly, as secondary infections and other treatable complications may be responsible for sudden decline.

Physical examination by a veterinarian experienced in ferret medicine provides initial assessment but cannot definitively diagnose Aleutian disease, as clinical signs are non-specific. Examination may reveal weight loss, muscle wasting, enlarged lymph nodes, splenomegaly, or other abnormalities consistent with chronic inflammatory disease. Neurological examination assesses for posterior paresis or other nervous system involvement. Abdominal palpation may detect organ enlargement. Oral examination checks for signs of bleeding or jaundice. However, many infected ferrets appear clinically normal, and symptomatic ferrets cannot be distinguished from other chronic diseases based on examination alone. The physical examination helps assess overall health status and identify areas requiring further investigation.

Diagnostic tests are essential for confirming Aleutian disease infection. The most commonly used screening tests detect antibodies against the virus, indicating exposure and infection. The counterimmunoelectrophoresis test and ELISA testing are standard methods. Positive antibody results confirm exposure but do not predict whether clinical disease will develop. Some veterinarians recommend polymerase chain reaction testing to detect viral DNA, providing more direct evidence of infection and potentially detecting early infection before antibody development. Blood chemistry panels typically reveal elevated total protein with increased globulins, often dramatically so. Complete blood count may show anemia, abnormal white cell counts, or platelet changes. Urinalysis often reveals protein in the urine from kidney damage.

Species-specific diagnostic considerations for Aleutian disease in ferrets include understanding test interpretation and limitations. Antibody tests may be negative very early in infection before seroconversion occurs. Some ferrets with chronic infection may have fluctuating antibody levels. Test sensitivity and specificity vary between laboratories and methods. Protein electrophoresis demonstrating polyclonal gammopathy provides supportive evidence. Organ function tests including kidney and liver values help assess disease severity and progression. Biopsy of affected organs showing plasmacytic inflammation and immune complex deposition provides definitive diagnosis but is invasive and rarely performed ante-mortem. Understanding that positive serology confirms infection but not disease status is important for management decisions.

Differential diagnosis for ferrets with clinical signs suspicious for Aleutian disease includes other causes of chronic weight loss and wasting. Lymphoma, one of the most common ferret cancers, causes similar wasting, lymph node enlargement, and organ dysfunction. Chronic gastrointestinal disease including inflammatory bowel disease causes weight loss and protein loss. Chronic kidney disease from other causes produces similar urinary and systemic signs. Cardiomyopathy can cause wasting and weakness. Other chronic infections must be considered. Concurrent conditions are common, as Aleutian disease may coexist with insulinoma, adrenal disease, or other ferret illnesses. Comprehensive diagnostic workup helps identify all contributing conditions and guides appropriate management.

Emergency and immediate treatment for ferrets with Aleutian disease focuses on addressing acute complications and stabilizing critical patients. Severely dehydrated ferrets require fluid therapy to restore hydration and support organ function. Anemic ferrets may need blood transfusion if anemia is severe and causing clinical compromise. Secondary bacterial infections require appropriate antibiotic therapy. Nutritional support including assisted feeding may be necessary for ferrets that have stopped eating. Pain management addresses discomfort from inflammation or organ involvement. Stabilizing acutely ill ferrets takes priority, with longer-term management planned once immediate crises are addressed.

Medical management of Aleutian disease remains limited since no antiviral treatments effectively eliminate the infection. Management focuses on supportive care and controlling symptoms. Anti-inflammatory medications may help reduce immune complex deposition and associated inflammation, though evidence for efficacy is limited. Prednisone or other corticosteroids are sometimes used but may have mixed effects given the immune-mediated nature of the disease. Immunosuppressive therapy has been attempted with variable results and potential risks. Treatment of secondary infections with appropriate antibiotics is important. Medications to protect kidney function may be beneficial when renal involvement is present. Nutritional supplementation supports overall health.

Surgical options are not applicable for treating Aleutian disease itself, as the condition is a systemic viral infection without surgical targets. Surgery may be indicated for concurrent conditions that develop in infected ferrets, such as tumor removal or dental work, but careful consideration of the ferret's overall health status and prognosis is necessary when planning elective procedures. Diagnostic procedures including lymph node or organ biopsies may be performed surgically when needed to rule out concurrent diseases like lymphoma.

Supportive care forms the cornerstone of Aleutian disease management. Maintaining adequate nutrition through high-quality diet and assisted feeding when necessary supports body condition. Ensuring adequate hydration through access to fresh water and subcutaneous fluids when needed maintains kidney function. Temperature regulation keeps ferrets comfortable. Clean, stress-free housing supports immune function and comfort. Regular cleaning and hygiene reduce secondary infection risk. Comfortable bedding supports ferrets with mobility issues. Monitoring and responding to symptoms as they develop helps maintain quality of life for as long as possible.

Species-specific treatment considerations for ferrets with Aleutian disease include their high metabolic rate requiring consistent nutrition, their susceptibility to hypoglycemia requiring regular feeding, and their propensity for concurrent conditions requiring comprehensive management. Ferrets with Aleutian disease may also develop insulinoma or adrenal disease requiring specific treatment. Drug dosing must account for small body size and altered metabolism in ill ferrets. The social nature of ferrets means that housing decisions affect both infected individuals and any healthy ferrets in the household. Access to exotic veterinary care with ferret experience optimizes management.

Treatment challenges in Aleutian disease are substantial given the lack of curative options. The unpredictable disease course makes prognostication difficult. Some ferrets remain stable for years while others decline rapidly. Determining when quality of life has declined to the point where euthanasia should be considered requires ongoing assessment and communication between owners and veterinarians. The risk of transmission to other ferrets creates housing and management challenges. Owner education about realistic expectations while maintaining hope for stable periods is important. Managing owner emotions when caring for ferrets with a chronic, incurable disease requires veterinary team support.

Recovery timeline discussions for Aleutian disease must acknowledge that this is a chronic, incurable infection rather than a condition that resolves with treatment. The concept of recovery in this context refers to stabilization of clinical signs and maintenance of quality of life rather than elimination of the virus or reversal of disease. Some ferrets remain asymptomatic carriers indefinitely, effectively representing the best possible outcome following infection. Symptomatic ferrets may stabilize with supportive care and maintain reasonable quality of life for extended periods, though the underlying disease remains. Acute episodes or crises may improve with intensive care, returning the ferret to their previous baseline.

Post-diagnosis care and monitoring become ongoing responsibilities for owners of ferrets with Aleutian disease. Regular veterinary check-ups, typically every three to six months for stable ferrets, allow monitoring of disease status and early detection of progression. Blood work including protein levels, kidney and liver values, and blood counts help track disease status over time. Weight monitoring at home between veterinary visits provides early warning of decline. Observation for new symptoms or worsening of existing signs allows timely intervention. Documenting symptoms and tracking changes helps identify trends that might be missed in day-to-day observation.

Prognosis factors for ferrets with Aleutian disease include the severity of disease at diagnosis, which organs are involved, how rapidly the disease is progressing, and individual response to supportive care. Ferrets diagnosed as asymptomatic carriers through routine testing may never develop clinical disease. Those with mild symptoms may remain stable for years. Ferrets with significant kidney involvement, severe neurological signs, or rapidly progressive wasting carry more guarded prognoses. The presence of concurrent conditions affects overall prognosis. Response to initial supportive care provides some indication of how an individual ferret may fare. However, the unpredictable nature of the disease makes long-term prognostication difficult in many cases.

Long-term outlook and quality of life for ferrets with Aleutian disease varies tremendously. Many positive ferrets live comfortable lives for months to years following diagnosis, particularly those that remain asymptomatic or have mild disease. Quality of life assessment should focus on whether the ferret can eat, maintain reasonable body condition, move around comfortably, engage in ferret behaviors, and is not in obvious distress. When quality of life deteriorates despite supportive care and cannot be restored to acceptable levels, humane euthanasia becomes the kindest option. Ongoing quality of life discussions between owners and veterinarians help ensure appropriate decisions are made at the right time.

Husbandry prevention strategies for Aleutian disease center on preventing exposure to infected ferrets and contaminated environments. Quarantine of new ferrets before introduction to existing ferrets, typically for two to four weeks with testing during or after quarantine, reduces transmission risk. Housing positive and negative ferrets separately prevents direct transmission. Thorough cleaning and disinfection with effective agents including dilute bleach eliminates environmental virus. Using separate equipment, food dishes, and bedding for positive and negative ferrets prevents fomite transmission. Washing hands and changing clothes between handling positive and negative animals reduces caregiver-mediated transmission. Isolation of any ferret showing illness pending diagnosis protects others.

Testing prevention strategies involve identifying infected ferrets before they can transmit the virus. Testing all new ferrets before introduction to existing collections allows informed decisions about housing. Annual or regular testing of ferrets in breeding programs, shelters, or multi-ferret households monitors for new infections. Testing before breeding prevents vertical transmission to offspring. Some facilities maintain closed colonies tested negative and avoid introducing outside ferrets. Testing ferrets before attending shows or events protects other attendees. Understanding test timing, as very early infections may not yet be detectable, informs appropriate testing protocols.

Stress reduction may help maintain immune function in exposed or infected ferrets. While stress reduction cannot prevent infection, optimizing immune health may influence whether exposed ferrets develop clinical disease. Appropriate housing, nutrition, and care reduce chronic stress. Avoiding overcrowding reduces both transmission risk and stress. Prompt treatment of other illnesses maintains overall health. Minimizing environmental changes and maintaining consistent routines supports well-being. Whether stress reduction truly affects Aleutian disease outcomes is uncertain, but promoting general health is beneficial regardless.

Regular health monitoring allows early detection of infection or disease development. Knowing baseline health parameters for each ferret helps detect subtle changes. Regular weighing identifies early weight loss. Observation for symptoms including changes in activity, appetite, or behavior prompts timely veterinary evaluation. For ferrets with known exposure history, monitoring is particularly important. Early detection of infection allows implementation of transmission prevention measures even before clinical disease develops. Early detection of clinical disease allows earlier supportive care intervention.

Veterinary check-ups with a ferret-experienced veterinarian support Aleutian disease prevention through professional guidance and testing. Discussion of risk factors helps owners make informed decisions about acquisition and housing of ferrets. Recommendations for appropriate testing protocols guide prevention strategies. Professional advice on quarantine procedures, disinfection, and management optimizes prevention efforts. When new ferrets are acquired, veterinary examination and testing before introduction protects existing animals. Ongoing veterinary relationships ensure access to testing and care when needed. No vaccine is currently available for Aleutian disease, making exposure prevention the primary strategy.

Ongoing daily care requirements for ferrets with Aleutian disease focus on maintaining nutrition, hydration, and comfort while monitoring for disease progression. High-quality nutrition supports body condition and immune function. Easy access to fresh water maintains hydration, with multiple water sources placed conveniently for ferrets with mobility limitations. Comfortable bedding in quiet resting areas supports recovery and comfort. Daily observation of eating, drinking, activity, and elimination patterns allows early detection of changes requiring attention. Ferrets requiring medication need consistent, low-stress administration routines. Temperature regulation through appropriate housing keeps ferrets comfortable. Maintaining normal ferret social interactions and enrichment activities supports quality of life.

Environmental management for ferrets with Aleutian disease includes both optimizing the affected ferret's environment and preventing transmission to others. Single-level housing or modified multi-level cages with easy access protects ferrets with weakness or incoordination from falls. Non-slip surfaces help ferrets with mobility issues. Easy litter box access encourages normal elimination. For households with both positive and negative ferrets, strict separation and hygiene protocols prevent transmission. Positive ferrets should have dedicated equipment, bedding, and housing. Areas should be thoroughly disinfected between uses by different ferrets. Some owners choose to keep only positive or only negative ferrets to simplify management.

Monitoring health indicators for ferrets with Aleutian disease extends to multiple body systems. Regular weighing, at least weekly, tracks body condition trends. Observing for neurological changes including rear leg weakness or wobbling detects nervous system progression. Monitoring eating and drinking helps assess appetite and hydration. Changes in urination or defecation may indicate kidney or gastrointestinal involvement. Noting activity levels and responsiveness helps gauge overall well-being. Any bleeding, breathing changes, or new symptoms warrant prompt attention. Keeping records of weights, symptoms, and observations helps track disease course and provides valuable information for veterinary visits.

Quality of life considerations are central to managing ferrets with Aleutian disease given the lack of curative treatment. Good quality of life means the ferret can eat and maintain reasonable body condition, move around well enough to access food and litter, engage in some normal ferret behaviors, and appears comfortable rather than in distress. Bad days should be infrequent and followed by good days. When bad days become predominant, mobility is severely compromised, eating stops despite assistance, or the ferret appears to be suffering, quality of life has declined beyond what supportive care can address. Regular quality of life assessment helps guide management decisions including timing of euthanasia when that becomes the most compassionate option.

Caregiver support and resources help owners manage the emotional and practical challenges of caring for ferrets with a chronic incurable disease. Ferret owner communities and online support groups connect owners dealing with Aleutian disease. Educational resources help owners understand the disease and management options. Maintaining veterinary team communication ensures guidance is available when questions arise or conditions change. Understanding that providing comfort care and quality time rather than cure can be meaningful helps owners feel positive about their role. Having honest discussions about prognosis and end-of-life planning reduces crisis decision-making stress. Grief support resources help when loss occurs. Self-care for caregivers prevents burnout during extended caregiving periods.

High-risk species for Aleutian disease among small mammals are limited to mustelids, with domestic ferrets and mink being the primary affected animals. The virus originated in mink populations, where the Aleutian color variant showed extreme susceptibility, giving the disease its name. Domestic ferrets acquired the virus through contact with infected mink or potentially through evolution of ferret-adapted viral strains. Other mustelid species may be susceptible but are rarely kept as pets. Non-mustelid small mammals including rabbits, guinea pigs, rats, hamsters, and other exotic pets are not susceptible to Aleutian disease virus and cannot become infected or transmit the disease.

Risk factors within the ferret population relate primarily to exposure opportunity. Ferrets from large breeding operations, pet stores, shelters, and rescues where many ferrets are housed have higher exposure risk than those from small breeders or single-ferret homes. Multi-ferret households have ongoing transmission risk if an infected ferret is introduced. Geographic areas with higher ferret populations may have higher viral prevalence. Attendance at ferret shows, playgroups, or events where ferrets from multiple sources mingle creates exposure opportunities. Young ferrets may be more susceptible to infection and disease development. Ferrets with compromised immune systems from other causes may be more vulnerable.

Species-specific susceptibilities affecting Aleutian disease in ferrets include individual genetic variation in immune response that influences whether infection leads to clinical disease or asymptomatic carrier status. Some ferret bloodlines may show higher susceptibility, though specific genetic markers have not been identified. The ferret immune system responds to infection with the characteristic plasmacytosis and hypergammaglobulinemia that cause immune complex disease, a response pattern that may differ from other species. Understanding these ferret-specific disease characteristics helps veterinarians and owners recognize and manage the condition appropriately. The lack of an effective vaccine for ferrets and the chronic carrier state make prevention through exposure avoidance the primary control strategy.

Commonly co-occurring conditions with Aleutian disease in ferrets reflect both the ferret's predisposition to multiple health issues and potential effects of chronic immune activation. Insulinoma and adrenal disease commonly affect the same age group of middle-aged and older ferrets, and may occur alongside Aleutian disease. Lymphoma and other cancers may develop in ferrets with chronic immune system abnormalities. Secondary bacterial infections occur more readily in immunocompromised ferrets. Chronic kidney disease from Aleutian disease-related damage may be exacerbated by concurrent conditions. Heart disease including cardiomyopathy affects older ferrets and can complicate management of ferrets with Aleutian disease. Comprehensive veterinary care addresses all concurrent conditions.

Conditions with similar symptoms to Aleutian disease must be differentiated through appropriate testing. Lymphoma causes similar wasting, lymph node enlargement, and organ involvement. Inflammatory bowel disease causes weight loss and poor body condition. Other causes of chronic kidney disease produce similar renal signs. Cardiomyopathy causes weakness and exercise intolerance. Chronic infections other than Aleutian disease can cause wasting and systemic illness. Dental disease severe enough to affect eating causes weight loss. Other causes of posterior paresis including spinal disease must be considered when neurological signs are present. Diagnostic testing including Aleutian disease-specific testing helps identify the correct diagnosis or reveals multiple concurrent conditions.

Secondary complications from Aleutian disease result from chronic immune complex deposition and organ damage. Chronic kidney disease with progressive renal failure is a common complication as immune complexes damage kidney tissue over time. Liver disease with elevated liver enzymes and eventual hepatic dysfunction occurs similarly. Chronic anemia from bone marrow suppression or chronic disease affects many symptomatic ferrets. Neurological dysfunction ranging from mild weakness to complete posterior paralysis can develop. Chronic inflammation may predispose to other infections or potentially to cancer development. Multi-organ failure eventually occurs in progressive cases. These complications are generally irreversible, though supportive care can help maintain quality of life for periods of time.